Cefquinome sulfate
CAS No. 118443-89-3
Cefquinome sulfate( Cefquinome Sulfate )
Catalog No. M17859 CAS No. 118443-89-3
Cefquinome Sulfate is a semisynthetic, broad-spectrum, fourth-generation aminothiazolyl cephalosporin with antibacterial activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 86 | In Stock |
|
| 1G | 124 | In Stock |
|
Biological Information
-
Product NameCefquinome sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefquinome Sulfate is a semisynthetic, broad-spectrum, fourth-generation aminothiazolyl cephalosporin with antibacterial activity.
-
DescriptionCefquinome Sulfate is a broad-spectrum fourth-generation cephalosporin antibiotic.
-
In Vitro——
-
In Vivo——
-
SynonymsCefquinome Sulfate
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorBacterial
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number118443-89-3
-
Formula Weight626.67
-
Molecular FormulaC23H26N6O9S3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (199.46 mM)
-
SMILESO=C(C(N12)=C(C[N+]3=C4CCCCC4=CC=C3)CS[C@]2([H])[C@H](NC(/C(C5=CSC(N)=N5)=N\OC)=O)C1=O)O.[O-]S(=O)(O)=O
-
Chemical Name(6R,7R)-7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(5,6,7,8-tetrahydroquinolin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrogensulfate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.B?ttner A,etal..Zentralbl Veterinarmed B. 1995 Aug;42(6):377-83.
molnova catalog
related products
-
GI 254023X
GI254023X is a potent MMP9 and ADAM10 inhibitor (IC50s: 2.5 and 5.3 nM) with 100-fold selectivity for the α-secretase ADAM10 over ADAM17 (TACE).
-
TAPI1
TAPI-1, an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.
-
MMP13-IN-3
MMP13-IN-3 is >1000 selective over other MMPs. MMP13-IN-3 is an effective, selective, and orally active MMP-13 inhibitor (IC50=1 nM) for the potential treatment of osteoarthritis.
Cart
sales@molnova.com